Geno Germano
Chairman presso SAGE THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Geno J.
Germano is currently the President, Chief Executive Officer & Director at Elucida Oncology, Inc., Chairman at SAGE Therapeutics, Inc., Independent Director at Precision BioSciences, Inc., and a Member of the Group of 50.
He previously held positions as a Director at The Medicines Co., Director at Biotechnology Innovation Organization, Director at Zoetis, Inc., Managing Director at Wyeth Australia Pty Ltd.
and Wyeth New Zealand, Independent Director at Bioverativ, Inc., President & General Manager-Specialty Care at Wyeth LLC, Group President-Global Innovative Pharma Business at Pfizer Inc., President at Precigen, Inc., and Trustee at Albany College of Pharmacy & Health Sciences.
Mr. Germano obtained his undergraduate degree from Albany College of Pharmacy & Health Sciences in 1983.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SAGE THERAPEUTICS, INC.
-.--% | 30/11/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
| 15/11/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Geno Germano
| Società | Posizione | Inizio |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Chairman | 05/01/2024 |
| PRECISION BIOSCIENCES, INC. | Director/Board Member | 10/03/2020 |
| Group of 50 | Corporate Officer/Principal | - |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Chief Executive Officer | 01/08/2018 |
Precedenti posizioni note di Geno Germano
| Società | Posizione | Fine |
|---|---|---|
| Albany College of Pharmacy & Health Sciences | Director/Board Member | 01/01/2018 |
| PRECIGEN, INC. | President | 10/03/2017 |
| PFIZER, INC. | Corporate Officer/Principal | 01/02/2016 |
| ZOETIS INC. | Director/Board Member | 24/06/2013 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | President | 01/10/2009 |
Formazione di Geno Germano
| Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| PRECISION BIOSCIENCES, INC. | Health Technology |
| ZOETIS INC. | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
| Group of 50 | |
| Wyeth Australia Pty Ltd. | |
| Wyeth New Zealand | |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Health Technology |
- Borsa valori
- Insiders
- Geno Germano
